vs
Insulet Corporation（PODD）与Rivian Automotive, Inc.（RIVN）财务数据对比。点击上方公司名可切换其他公司
Rivian Automotive, Inc.的季度营收约是Insulet Corporation的1.6倍（$1.3B vs $783.7M），Insulet Corporation净利率更高（13.0% vs -63.1%，领先76.0%），Insulet Corporation同比增速更快（31.2% vs -25.8%），Insulet Corporation自由现金流更多（$48.2M vs $-1.1B），过去两年Insulet Corporation的营收复合增速更高（33.2% vs 3.3%）
Insulet Corporation是深耕糖尿病治疗领域的医疗器械企业，核心产品为胰岛素泵，通过持续皮下输注胰岛素的疗法为患者给药。其产品通常由泵主体、一次性胰岛素储药仓，以及包含皮下植入套管和连接管路的一次性输注套件构成，满足不同患者的治疗需求。
Rivian Automotive是2009年成立的美国电动汽车制造商及汽车科技企业，主打基于自研滑板平台打造的电动SUV、皮卡及EDV电动配送货车，旗下R1T皮卡于2021年末正式开启交付，还计划于2023年底前在美国和加拿大布局专属充电网络，其平台可适配新车型也可对外授权使用。
PODD vs RIVN — 直观对比
营收规模更大
RIVN
是对方的1.6倍
$783.7M
营收增速更快
PODD
高出57.0%
-25.8%
净利率更高
PODD
高出76.0%
-63.1%
自由现金流更多
PODD
多$1.2B
$-1.1B
两年增速更快
PODD
近两年复合增速
3.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $783.7M | $1.3B |
| 净利润 | $101.6M | $-811.0M |
| 毛利率 | 72.6% | 9.3% |
| 营业利润率 | 18.7% | -64.8% |
| 净利率 | 13.0% | -63.1% |
| 营收同比 | 31.2% | -25.8% |
| 净利润同比 | 0.9% | -9.0% |
| 每股收益（稀释后） | $1.42 | $-0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PODDRIVN
| Q4 25 | $783.7M | $1.3B | ||
| Q3 25 | $706.3M | $1.6B | ||
| Q2 25 | $649.1M | $1.3B | ||
| Q1 25 | $569.0M | $1.2B | ||
| Q4 24 | $597.5M | $1.7B | ||
| Q3 24 | $543.9M | $874.0M | ||
| Q2 24 | $488.5M | $1.2B | ||
| Q1 24 | $441.7M | $1.2B |
净利润PODDRIVN
| Q4 25 | $101.6M | $-811.0M | ||
| Q3 25 | $87.6M | $-1.2B | ||
| Q2 25 | $22.5M | $-1.1B | ||
| Q1 25 | $35.4M | $-545.0M | ||
| Q4 24 | $100.7M | $-744.0M | ||
| Q3 24 | $77.5M | $-1.1B | ||
| Q2 24 | $188.6M | $-1.5B | ||
| Q1 24 | $51.5M | $-1.4B |
毛利率PODDRIVN
| Q4 25 | 72.6% | 9.3% | ||
| Q3 25 | 72.2% | 1.5% | ||
| Q2 25 | 69.7% | -15.8% | ||
| Q1 25 | 71.9% | 16.6% | ||
| Q4 24 | 72.1% | 9.8% | ||
| Q3 24 | 69.3% | -44.9% | ||
| Q2 24 | 67.7% | -38.9% | ||
| Q1 24 | 69.5% | -43.8% |
营业利润率PODDRIVN
| Q4 25 | 18.7% | -64.8% | ||
| Q3 25 | 16.7% | -63.1% | ||
| Q2 25 | 18.7% | -85.5% | ||
| Q1 25 | 15.6% | -52.8% | ||
| Q4 24 | 18.3% | -38.1% | ||
| Q3 24 | 16.2% | -133.8% | ||
| Q2 24 | 11.2% | -118.7% | ||
| Q1 24 | 12.9% | -123.3% |
净利率PODDRIVN
| Q4 25 | 13.0% | -63.1% | ||
| Q3 25 | 12.4% | -75.3% | ||
| Q2 25 | 3.5% | -85.7% | ||
| Q1 25 | 6.2% | -44.0% | ||
| Q4 24 | 16.9% | -42.9% | ||
| Q3 24 | 14.2% | -125.9% | ||
| Q2 24 | 38.6% | -125.8% | ||
| Q1 24 | 11.7% | -120.1% |
每股收益（稀释后）PODDRIVN
| Q4 25 | $1.42 | $-0.66 | ||
| Q3 25 | $1.24 | $-0.96 | ||
| Q2 25 | $0.32 | $-0.97 | ||
| Q1 25 | $0.50 | $-0.48 | ||
| Q4 24 | $1.38 | $-0.67 | ||
| Q3 24 | $1.08 | $-1.08 | ||
| Q2 24 | $2.59 | $-1.46 | ||
| Q1 24 | $0.73 | $-1.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $6.1B |
| 总债务越低越好 | $930.8M | — |
| 股东权益账面价值 | $1.5B | $4.6B |
| 总资产 | $3.2B | $14.9B |
| 负债/权益比越低杠杆越低 | 0.61× | — |
8季度趋势，按日历期对齐
现金及短期投资PODDRIVN
| Q4 25 | — | $6.1B | ||
| Q3 25 | — | $7.1B | ||
| Q2 25 | — | $7.5B | ||
| Q1 25 | — | $7.2B | ||
| Q4 24 | — | $7.7B | ||
| Q3 24 | — | $6.7B | ||
| Q2 24 | — | $7.9B | ||
| Q1 24 | — | $7.9B |
总债务PODDRIVN
| Q4 25 | $930.8M | — | ||
| Q3 25 | $934.9M | — | ||
| Q2 25 | $939.0M | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | $5.5B | ||
| Q1 24 | $1.4B | $4.4B |
股东权益PODDRIVN
| Q4 25 | $1.5B | $4.6B | ||
| Q3 25 | $1.4B | $5.1B | ||
| Q2 25 | $1.5B | $6.1B | ||
| Q1 25 | $1.3B | $6.2B | ||
| Q4 24 | $1.2B | $6.6B | ||
| Q3 24 | $1.1B | $5.9B | ||
| Q2 24 | $998.4M | $6.8B | ||
| Q1 24 | $790.7M | $8.1B |
总资产PODDRIVN
| Q4 25 | $3.2B | $14.9B | ||
| Q3 25 | $3.0B | $15.2B | ||
| Q2 25 | $3.5B | $15.6B | ||
| Q1 25 | $3.5B | $15.5B | ||
| Q4 24 | $3.1B | $15.4B | ||
| Q3 24 | $3.0B | $14.3B | ||
| Q2 24 | $2.9B | $15.4B | ||
| Q1 24 | $2.6B | $15.7B |
负债/权益比PODDRIVN
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.68× | — | ||
| Q2 25 | 0.64× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | 1.07× | — | ||
| Q3 24 | 1.21× | — | ||
| Q2 24 | 1.36× | 0.81× | ||
| Q1 24 | 1.72× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.3M | $-681.0M |
| 自由现金流经营现金流 - 资本支出 | $48.2M | $-1.1B |
| 自由现金流率自由现金流/营收 | 6.2% | -89.0% |
| 资本支出强度资本支出/营收 | 17.2% | 36.0% |
| 现金转化率经营现金流/净利润 | 1.80× | — |
| 过去12个月自由现金流最近4个季度 | $377.7M | $-2.5B |
8季度趋势，按日历期对齐
经营现金流PODDRIVN
| Q4 25 | $183.3M | $-681.0M | ||
| Q3 25 | $125.7M | $26.0M | ||
| Q2 25 | $196.5M | $64.0M | ||
| Q1 25 | $63.8M | $-188.0M | ||
| Q4 24 | $147.7M | $1.2B | ||
| Q3 24 | $98.5M | $-876.0M | ||
| Q2 24 | $96.5M | $-754.0M | ||
| Q1 24 | $87.6M | $-1.3B |
自由现金流PODDRIVN
| Q4 25 | $48.2M | $-1.1B | ||
| Q3 25 | $100.1M | $-421.0M | ||
| Q2 25 | $177.9M | $-398.0M | ||
| Q1 25 | $51.5M | $-526.0M | ||
| Q4 24 | $94.1M | $856.0M | ||
| Q3 24 | $71.8M | $-1.2B | ||
| Q2 24 | $74.0M | $-1.0B | ||
| Q1 24 | $65.5M | $-1.5B |
自由现金流率PODDRIVN
| Q4 25 | 6.2% | -89.0% | ||
| Q3 25 | 14.2% | -27.0% | ||
| Q2 25 | 27.4% | -30.5% | ||
| Q1 25 | 9.1% | -42.4% | ||
| Q4 24 | 15.7% | 49.4% | ||
| Q3 24 | 13.2% | -131.9% | ||
| Q2 24 | 15.1% | -89.6% | ||
| Q1 24 | 14.8% | -126.5% |
资本支出强度PODDRIVN
| Q4 25 | 17.2% | 36.0% | ||
| Q3 25 | 3.6% | 28.7% | ||
| Q2 25 | 2.9% | 35.5% | ||
| Q1 25 | 2.2% | 27.3% | ||
| Q4 24 | 9.0% | 18.9% | ||
| Q3 24 | 4.9% | 31.7% | ||
| Q2 24 | 4.6% | 24.4% | ||
| Q1 24 | 5.0% | 21.1% |
现金转化率PODDRIVN
| Q4 25 | 1.80× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 8.73× | — | ||
| Q1 25 | 1.80× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 0.51× | — | ||
| Q1 24 | 1.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
RIVN
| Automotive Segment | $839.0M | 65% |
| Software And Services Segment | $447.0M | 35% |
| Regulatory Credits | $30.0M | 2% |
